In a new report, the New York Times details multiple incidents of the insurance giant using legal threats to silence social media users and news outlets, citing the murder of Brian Thompson and the threat of rising violence as the basis for its claims. 

The Consumer Financial Protection Bureau joined trade lobby groups in asking a federal court to vacate the rule, which would have forbidden creditors from considering medical debt in lending decisions.

Under the direction of U.S. Attorney General Pam Bondi, charges against Michael Kirk Moore Jr., MD, were dropped just as his trial began. He had been accused of destroying 1,937 doses of COVID-19 vaccines and accepting kickbacks for falsifying vaccine records.

In the past year, there has been a record number of new medical AI submissions, resulting in 300 new clinical AI clearances. The number of submissions has been steadily rising over the past decade.

After issuing a 50% tariff on copper imports this week, President Donald Trump said a massive levy on drugs could be announced “very soon.” The details are currently unknown. 

Shareholders of the retail pharmacy giant voted in favor of the terms of the sale to Sycamore Partners for $11.45 a share. The deal is expected to close later this year. 

American Medical Association (AMA) Board of Trustees Member Scott Ferguson, MD, explains the concern that a large number of rural hospitals will close under the massive Medicaid cuts in the "Big, Beautiful Bill" passed by Congress in July 2025.  

An urgent device recall has been issued on Bravo CF, a line of pH capsules that are placed in the esophagus to aid in understanding the effects of acid reflux. Due to a dangerous manufacturing error, certain lots of the devices must be quarantined immediately.

A report from the Chartis Center for Rural Health warns that many hospitals in rural communities are at risk of closure if Medicaid cuts pass through Congress and are enacted by President Donald Trump. According to the analysis, women and newborns will disproportionately lose access to care. 

Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.

“Leaders in radiology must prioritize embedding a culture of feedback within their institutions, recognizing its crucial role in continuous improvement," experts charge.